These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 17327450)

  • 1. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
    Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
    Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
    Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
    Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
    Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.
    Jiang C; Kim JH; Li F; Qu A; Gavrilova O; Shah YM; Gonzalez FJ
    J Biol Chem; 2013 Feb; 288(6):3844-57. PubMed ID: 23255598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.
    Kudoh A; Satoh H; Hirai H; Watanabe T
    Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term interleukin-1alpha treatment inhibits insulin signaling via IL-6 production and SOCS3 expression in 3T3-L1 adipocytes.
    Uno T; He J; Usui I; Kanatani Y; Bukhari A; Fujisaka S; Yamazaki Y; Suzuki H; Iwata M; Ishiki M; Urakaze M; Haruta T; Ogawa H; Kobayashi M
    Horm Metab Res; 2008 Jan; 40(1):8-12. PubMed ID: 18085494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice.
    Aoyama T; Ikejima K; Kon K; Okumura K; Arai K; Watanabe S
    Hepatology; 2009 May; 49(5):1636-44. PubMed ID: 19205029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
    Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte.
    Liu Z; Gan L; Zhou Z; Jin W; Sun C
    Immunobiology; 2015 Aug; 220(8):947-53. PubMed ID: 25720636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
    Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
    J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice.
    Sharma M; Mohapatra J; Malik U; Nagar J; Chatterjee A; Ramachandran B; Jain MR
    J Diabetes; 2017 Jun; 9(6):613-621. PubMed ID: 27530729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor α and suppressor of cytokine signaling 3.
    Jiang Y; Thakran S; Bheemreddy R; Ye EA; He H; Walker RJ; Steinle JJ
    J Biol Chem; 2014 Sep; 289(38):26395-26405. PubMed ID: 25086044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
    Zheng F; Zhang S; Lu W; Wu F; Yin X; Yu D; Pan Q; Li H
    PLoS One; 2014; 9(6):e101269. PubMed ID: 24972069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.
    Collino M; Aragno M; Castiglia S; Miglio G; Tomasinelli C; Boccuzzi G; Thiemermann C; Fantozzi R
    Br J Pharmacol; 2010 Aug; 160(8):1892-902. PubMed ID: 20233219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats.
    Lv Q; Wang Y; Wang W; Wang L; Zhou X
    Endocr Res; 2009; 34(4):130-41. PubMed ID: 19878073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase.
    Pereira RI; Leitner JW; Erickson C; Draznin B
    Life Sci; 2008 Nov; 83(19-20):638-43. PubMed ID: 18824177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
    Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
    Nakano S; Inada Y; Masuzaki H; Tanaka T; Yasue S; Ishii T; Arai N; Ebihara K; Hosoda K; Maruyama K; Yamazaki Y; Shibata N; Nakao K
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.